Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study-Reference-Cited by-同舟云学术

Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study

Published:2019-12 Issue:1 Volume:40 Page:63-72
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharmacol Rep

Author:

Harvey Philip D.¹^ORCID,Nakamura Hiroshi²^ORCID,Miura Sadanori³

Affiliation:

1. Leonard M. Miller Professor of Psychiatry and Behavioral Sciences University of Miami, Miller School of Medicine Miami FL USA

2. Medical Affairs Sumitomo Dainippon Pharma Co., Ltd Tokyo Japan

3. Kitasato University School of Medicine Kanagawa Japan

Funder

Dainippon Sumitomo Pharma

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12089

Reference28 articles.

1. Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials

2. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

3. Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options

4. Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of social functioning in patients with first-episode schizophrenia using blonanserin treatment: a prospective, multi-centre, single-arm clinical trial;Frontiers in Psychiatry;2024-03-20

2. Efficacy of add-on blonanserin in treatment-resistant schizophrenia therapy: A retrospective cohort study;Asian Journal of Psychiatry;2024-01

3. Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials;BMC Psychiatry;2023-10-11

4. Safety and effectiveness of oral blonanserin for schizophrenia in adolescents in China: Data from a 12-week post-marketing surveillance;The European Journal of Psychiatry;2023-10

5. Bioequivalence of Blonanserin Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2023-09-23